FNY Investment Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

FNY Investment Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-180,106	Closed	-$7.08M	–	822
2023 Q2	$7.08M	Buy	+180,106	New	+$6.36M	8.98%	1
2020 Q3	–	Sell	-1,500	Closed	-$7K	–	649
2020 Q2	$7K	Buy	+1,500	New	+$6.25K	﹤0.01%	301

FNY Investment Advisers's ISEE Position: Q3 2023 in Review

FNY Investment Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 180,106 shares — an estimated $7.08M sold.

FNY Investment Advisers first reported a position in ISEE in Q2 2020 and held it in 2 quarters. The position peaked at $7.08M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

FNY Investment Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
FNY Investment Advisers sold 180,106 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $7.08M.
FNY Investment Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
FNY Investment Advisers's IVERIC bio, Inc. Common Stock position peaked at $7.08M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.